Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours
- 31 July 1996
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 32 (8), 1325-1331
- https://doi.org/10.1016/0959-8049(96)00048-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.The Journal of cell biology, 1995
- Recent advances in the study of dendritic cells and follicular dendritic cellsImmunology Today, 1995
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Vaccinia Virus MUC1 Immunization of MiceJournal of Immunotherapy, 1993
- Cell membrane-associated mucins and their adhesion-modulating propertyTrends in Biochemical Sciences, 1992
- Dendritic cells as specialized antigen-presenting cellsResearch in Immunology, 1989
- DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIESThe Lancet, 1988
- Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.JCI Insight, 1985
- Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumorsInternational Journal of Cancer, 1984
- Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in cultureInternational Journal of Cancer, 1981